← Leaderboards
Glen Taksler
Cleveland Clinic Lerner Com-Cwru
$3,866,807
Attributed
$3,866,807
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $795.2K · FY2017–23$1M$750K$500K$250K$0
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$3,866,807 · 2
By mechanism
R01$3,410,193 · 1
R21$456,614 · 1
Top collaborators
No co-investigators on record.
Most similar at Cleveland Clinic Lerner Com-Cwru
Same institution · by research overlap
- Lan Zhou$4,689,034
- Kathryn Anne Martinez$1,855,155
Others in their field
Other Emerging Leaders on “Preventive Service”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Kimberly Smith · Ppd Development Lp$122,008,792
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$79,064,225
- Leonard Freedman · Leidos Biomedical Research, Inc.$71,569,696
- Prasant Mohapatra · University Of California At Davis$41,945,816
- Steven A. Ackerman · University Of Wisconsin-Madison$38,898,438
Research focus
Preventive ServiceRacePhysiciansPreventive CareProviderPublishingFoundationsMiddle AgePreventPreventionAge FactorsAdherenceAging PopulationBehaviorAdultDisorder PreventionEvidence BaseLife ExpectancyCare DeliveryLifeDecision AidHealth Care ServiceChronic DiseaseRandomized Trial
Grant awards (9)
Testing the Effectiveness of Individualized Disease Prevention for Middle-Aged Adults$592,300
R01 · FY2023 · AG · contact PI
Testing the Effectiveness of Individualized Disease Prevention for Middle-Aged Adults$583,643
R01 · FY2022 · AG · contact PI
Testing the Effectiveness of Individualized Disease Prevention for Middle-Aged Adults$161,000
R01 · FY2022 · AG · contact PI
Testing the Effectiveness of Individualized Disease Prevention for Middle-Aged Adults$634,181
R01 · FY2021 · AG · contact PI
Testing the Effectiveness of Individualized Disease Prevention for Middle-Aged Adults$161,000
R01 · FY2021 · AG · contact PI
Testing the Effectiveness of Individualized Disease Prevention for Middle-Aged Adults$577,056
R01 · FY2020 · AG · contact PI
Testing the Effectiveness of Individualized Disease Prevention for Middle-Aged Adults$701,013
R01 · FY2019 · AG · contact PI
Individualizing Disease Prevention for Middle-Aged Adults$128,307
R21 · FY2018 · AG · contact PI
Individualizing Disease Prevention for Middle-Aged Adults$328,307
R21 · FY2017 · AG · contact PI